Cronos Group (TSE:CRON) Given a C$4.50 Price Target by TD Securities Analysts

Cronos Group (TSE:CRON) has been given a C$4.50 price objective by analysts at TD Securities in a report issued on Tuesday,BayStreet.CA reports. The firm presently has a “buy” rating on the stock. TD Securities’ price target indicates a potential upside of 19.68% from the company’s current price.

Separately, Canaccord Genuity Group set a C$4.25 target price on Cronos Group and gave the company a “buy” rating in a research report on Tuesday, January 27th. Two analysts have rated the stock with a Buy rating, According to MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of C$4.38.

Cronos Group Trading Up 3.9%

TSE:CRON traded up C$0.14 on Tuesday, hitting C$3.76. 67,932 shares of the stock were exchanged, compared to its average volume of 162,264. The company’s 50-day moving average price is C$3.68 and its 200 day moving average price is C$3.60. Cronos Group has a 52 week low of C$2.27 and a 52 week high of C$4.66. The stock has a market capitalization of C$1.44 billion, a price-to-earnings ratio of 34.18, a P/E/G ratio of 0.12 and a beta of 1.21. The company has a debt-to-equity ratio of 0.17, a quick ratio of 24.01 and a current ratio of 24.24.

About Cronos Group

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S.